The tumor suppressor protein, p53 is a transcription factor which not only activates expression of genes containing the p53 binding site but also can repress the expression of some genes lacking this binding site. Previous studies have shown that overexpression of wild type p53 leads to apoptosis and cell cycle arrest. DNA damage, such as that caused by UV irradiation, results in p53 stabilization and nuclear localization that subsequently induces apoptosis. Recently, the level of calreticulin (CRT) has been correlated with the rate of apoptosis. Therefore, the aim of this study was to investigate role of CRT in the regulation of apoptosis via modulating p53 function and expression. Here we show a significant decrease in both basal and DNA damage induced p53 functions in the CRT deficient cells (crt-/-). This study is the first to demonstrate that CRT function is required for the stability and localization of the p53 protein. By using immuonocytochemical techniques, we showed that observed changes in p53 in the crt-/-cells are due to the nuclear accumulation of Mdm2 (murine double minute gene). These results, lead us to conclude that CRT regulates p53 function by affecting its rate of degradation and nuclear localization.
Introduction
p53 is a transcription factor important for both regulating the cell cycle progression and the induction of apoptosis in a variety of cells. In vivo, this protein functions as a tumor suppressor, indeed over 50% of all human cancers have been characterized with mutations in the p53 gene (Hollstein et al., 1991; Ko and Prives, 1996) . Furthermore, gene targeted deletion of p53 in mice results in mice which have an increased susceptibility to the development of multiple tumors (Donehower et al., 1992) (Donehower, 1996) . In normal proliferating cells, the p53 protein has a short half life (Ashcroft and Vousden, 1999) and it continuously shuttles between the nucleus and the cytoplasm (Middeler et al., 1997) . Under stresses such as UV irradiation, chemotherapeutic agents or hypoxia, p53 is stabilized and accumulates in the nucleus (Lain et al., 1999a; Lain et al., 1999b; Ashcroft et al., 2000; Zhang and Xiong, 2001) where it activates expression of the stress response genes (Middeler et al., 1997) resulting in cell cycle arrest (Reich and Levine, 1984) and apoptosis (Cotton and Spandau, 1997; Reinke and Lozano, 1997) . Therefore, the efficient regulation of p53 function is important for determining cell survival and proliferation.
Given the pivotal role of p53 in the cell, several mechanisms are involved in the regulation of its function, including regulation of its nuclear localization, regulation of protein stability and post-translational modifications (e.g. phosphorylation and acetylation) (for review see Woods and Vousden, 2001) . One of the proteins important in regulation of p53 is Mdm2 (murine double minute gene). Mdm2 is a member of the RING-Finger protein family of E3 ubiquitin ligases (Honda et al., 1997; Fang et al., 2000) and is involved in ubiqutinylation of p53 (Fang et al., 2000) . Interaction of Mdm2 4 with p53 mediates p53 export from the nucleus to the cytoplasm (Tao and Levine, 1999; Inoue et al., 2001) where p53 undergoes degradation via the proteasome pathway (Haupt et al., 1997; Yu et al., 2000) . Interestingly, UV induced activation of p53 has been shown to increase the expression level of Mdm2 in vivo (Saucedo et al., 1998; Wu and Levine, 1997) . Furthermore, the activity of Mdm2 and its nuclear translocation has been shown to be regulated by phosphorylation via AKT (protein kinase B) (Mayo et al., 2002; Mayo and Donner, 2001 ).
Calreticulin (CRT) is a ubiquitous eukaryotic protein which is localized to the endoplasmic/sarcoplasmic reticulum and to the nuclear envelope lumen. Several unique functions have been postulated for CRT (reviewed in Michalak et al., 1999) including chaperone activity (Nigam et al., 1994; Nauseef et al., 1995; Hebert et al., 1997) and regulation of Ca 2+ homeostasis (Liu et al., 1994; Camacho and Lechleiter, 1995; Bastianutto et al., 1995; Mery et al., 1996; Coppolino et al., 1997) . Recently, CRT has also been shown to be involved regulation of nuclear transport (both import and export) of: NFAT3, , MEF2C (Li et al., 2002) and glucocorticoid receptor (Holaska et al., 2001; Holaska et al., 2002) . Interestingly, changes in the CRT expression have been shown to alter the response of cells to pro-apoptotic signals (Nakamura et al., 2000; Kageyama et al., 2002) . CRT overexpressing cells show increased sensitivity to drug induced apoptosis (Nakamura et al., 2000; Kageyama et al., 2002) , whereas CRT deficient cells were more resistant to drug or UV induced apoptosis (Nakamura et al., 2000) . Therefore, the aim of this study was to investigate the functional role of CRT in regulating p53 expression, localization and function.
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Material and Methods
Plasmids
Vectors containing p53EGFP fusion protein (pp53-EGFP) and the Luciferase gene under control of the p53 response element (pp53-TA-Luc) were purchased from BD Biosciences Clontech. The cDNA encoding full length CRT tagged with Hemagglutinin epitope tag (HA) was a generous gift from Dr. Michalak (University of Alberta, Edmonton, Alberta). For generation of stably transfected cell line, the HA-CRT cDNA was cloned in the pcDNA3.1 plasmid containing the hygromycin resistance (Invitrogen).
Plasmid containing the human p53 promoter (h-p53-luc) was a generous gift from Dr.
Reisman (University of South Carolina, Columbia, South Carolina). For the transfection experiments, plasmids were purified using DNA purification kits from QIAGEN.
Cell Culture
Mouse embryonic fibroblast cells (MEF) were isolated from wild type (wt) and calreticulin knockout (crt-/-) 14 day old mouse embryos as described previously . Briefly, embryos were washed in ice cold PBS, dissociated and trypsinized for 30 min. Dispersed cells were then cultured in DMEM containing 20% fetal calf serum. The primary MEF cells were immortalized by transfection with SV40 T-large antigen. To test that the observed effects were due to loss of CRT function, crt-/-MEF cells were stably transfected with pcDNA-CRT-HA using the Ca 2+ phosphate transfection protocol as described previously (Waser et al., 1997) . Transfected cells were cultured in the presence of 100 µg/ml of hygromycin for 2 weeks, after which single colonies were 6 isolated, expanded and screened for the expression of CRT (hereafter will be referred to as CRT-crt-/-cells).
Immunoblotting and Immunocytochemistry
For western blot analysis of p53 expression, cells were treated for 2 hrs with 20 µM ALLN (N-Acetyl-Leu-Leu-Nle-CHO, CALBIOCHEM). Cell were then washed with icecold PBS and lysed in RIPA buffer containing a protease inhibitor cocktail (Sigma) . Monoclonal anti-p53 antibody was purchased from Oncogene.
CRT expression in wt, crt-/-and CRT-crt-/-cells was detected by using Goat anti-CRT (a gift from Dr. Michalak). For analysis of Mdm2 protein expression, western blot was carried out using a polyclonal anti-Mdm2 antibody (C-18) from Santa Cruz.
To check the localization of endogenous p53 and Mdm2, cells were plated on coverslips at a density of 50,000 cells per well in 6 well plates. Prior to treatment, media was changed with fresh media containing 20 µM ALLN. Coverslips were divided to three groups, non-treated, UV (25J/m 2 ) treated followed by 2 or 6 hrs recovery. Cells were then fixed in 4% paraformaldehyde in PBS for 10 min. For localization of p53, monoclonal anti-p53 (Ab-1, Oncogene) was used at a 5 µg/ml concentration. Monoclonal anti-Mdm2
(Ab-4, Oncogene) was used at a concentration of 2 µg/ml for immunolocalization of coverslips were divided to 3 groups as described above. The EGFP signal was then colocalized with DAPI.
Apoptosis assay
To assess the degree of apoptosis following UV treatment, equal number of cells (2x10 6 in 10 cm 2 plates) was plated on coverslips. The next day cells were exposed to UV and left to recover for either 2 or 6 hrs as described above. Apoptosis was then determined using a TUNEL based assay, In Situ Cell Death Detection Kit, Fluorescein (Roche Applied Science) following the manufactures protocol. In brief, following the recovery period (2 or 6 hrs) cells were fixed for 1 hr in 2% paraformaldehyde in PBS. Cells were then permeablized and incubated with TUNEL reaction mixture for 1 hr at 37 °C, followed by 3 washes with PBS. The coverslips were then mounted using Vectashield mounting media containing DAPI (Vector laboratories, Inc.). The FITC and DAPI images were obtained using a Zeiss epi-flourescent microscope. These images were superimposed to detect the apoptotic nuclei (FITC labeled).
Reporter gene assays
wt and crt-/-MEF cells were plated at a density of 50,000 per plate (in 3 cm 2 plates) and transiently co-transfected with either pSV-β-gal and pp53-TA-luc, or pSV-β-gal and hp53-luc using Lipofectamine (Invitrogen). 48 hrs after the transfection cells were lysed 8 and luciferase and β-galactosidase assays were carried out as described in Waser et. al. (Waser et al., 1997) .
Reverse Transcriptase assay
Total RNA was isolated from the wt, crt-/-and CRT-crt-/-cells using Trizole reagent shows a response to UV that is similar to what is seen in the wt cells ( Figure 1C ). These results are in agreement with previous reports on CRT dependent changes in resistance to apoptosis (Nakamura et al., 2000; Kageyama et al., 2002) . UVA and UVB have been shown to activate p53 resulting in its stabilization, nuclear localization and increased transcriptional activity (Liu and Pelling, 1995; Bellamy et al., 1997) . Activated p53
translocates to the nucleus where it binds to the p53 response element present in the promoter region of a number of genes which are involved in cell fate determination (e.g.
Mdm2, p21, Cyclin G, GADD45, for review see (Levine, 1997) ). Therefore, we compared the transcriptional activity of p53 in CRT deficient (crt-/-) cells with wt cells and CRT deficient cells which were stably transfected with CRT (CRT-crt-/-) ( Figure   1D ). wt, crt-/-and CRT-crt-/-MEF cells were transiently transfected with a plasmid containing a p53 response element upstream of the luciferase reporter gene. There was a significant decrease (5 fold) in the p53 mediated reporter gene regulation in the crt-/-cells as compared to wt cells ( Figure 1D ), a process which was partially reversed by transfecting the crt-/-cells with CRT ( Figure 1D , CRT-crt-/-). These results emphasize that the increased resistance of crt-/-cells to UV induced apoptosis could be due to impaired p53 function. To examine the role of CRT in regulation of p53 function, we studied the expression level and localization of p53 in the wt and crt-/-MEF cells.
p53 localization
DNA damage, by chemicals such as doxorubicin or UV irradiation, results in the activation of p53 which is accompanied by its stabilization and nuclear accumulation.
Increased nuclear p53 leads to cell cycle arrest and apoptosis. In many types of cancer tumor development has been attributed to the failure of p53 translocation to the nucleus.
Therefore we determined the subcellular localization of p53 protein in cells expressing different levels of CRT using immuonocytochemical techniques. Due to the short half life of p53, we pretreated the cells with the calpain inhibitor, ALLN (as described in the Materials and Methods). In the absence of ALLN treatment p53 protein was undetectable (data not shown). In MEF cells containing CRT (wt and CRT-crt-/-) p53 co-localizes predominantly with the DAPI nuclear stain (Figure 2A and 2C). However, in CRT deficient cells ( Figure 2B ) p53 fails to localize to the nucleus. This change in the nuclear localization of p53 can partially account for the observed alteration in p53 function. We and others (Li et al., 2002) have previously shown a defect in the nuclear transport of NF-AT3 and MEF2C (transcription factors) in the crt-/-cells. On the other hand, the nuclear transport of GATA4 (Li et al., 2002) and glucocorticoid receptor (Holaska et al., 2001) was not changed in the crt-/-cells emphasizing that the defect in the nuclear transport is not a general phenomena in the absence of CRT.
p53 protein expression
As mentioned above, p53 protein has a very short half life (15-20 min) and its level is actively regulated by protein degradation by both the calpain and the proteasome pathways. Thus we examined the expression level of p53 protein with altered CRT expression. There was a significant decrease in the level of p53 protein in the crt-/-cells (49% of wt, Figure 3A ). To determine if this observation was specific to loss of CRT function, we transfected crt-/-cells with CRT-HA and established stable cell lines (CRT-
crt-/-).
In these cells the CRT expression was restored to 60% of the wt levels of CRT ( Figure 3B ). Furthermore, these cells showed a partial recovery of the level of p53
protein (75% of wt) ( Figure 3A bar graph). To confirm that the decrease in the p53
protein level in the absence of CRT is not due to the use of established cell lines, we determined the level of p53 expression in the wt, heterozygous (crt+/-) and homozygous (crt-/-) CRT deficient mouse embryos ( Figure 3C ). As shown previously ) (also in Figure 3C ) the level of CRT protein in the heterozygous (crt+/-) mouse embryos is half of that in wild type mouse embryo. Figure 3C shows that the expression of p53 protein is significantly decreased in the heterozygous (crt+/-) mouse embryos, whereas in the homozygous CRT deficient (crt-/-) mouse embryo the p53 protein is barely detectable.
The decreased level of p53 protein in crt-/-cells could be due either to decreased transcription of p53 gene or rapid degradation of the p53 protein. Thus we investigated whether p53 gene transcription was altered by different levels of cellular CRT. In these studies cells were transfected with a plasmid containing the luciferase reporter gene under control of the human p53 promoter. To normalize for transfection efficiency cells were co-transfected with a control β-gal plasmid. Surprisingly, we observed a significant (2.5 fold) increase in the p53 promoter activation in the crt-/-cells as seen in Figure 4 . In addition we showed that re-introduction of CRT in crt-/-cells resulted in a decrease in the p53 promoter activity (Figure 4 ). This finding illustrates that the decrease in the p53 protein in crt-/-cells is not due to inhibition of p53 gene transcription but due to a posttranscriptional mechanism such as ubiquitin mediated degradation.
Mdm2 localization
Activation of Mdm2 via Akt/PKB phosphorylation results in its translocation to the nucleus where it interacts with p53 (Tao and Levine, 1999; Inoue et al., 2001; Mayo and Donner, 2001 ). The process of p53 degradation is initiated by Mdm2 mediated ubiquitination and translocation to the cytoplasm where p53 is degraded by the proteasome dependent pathway (Haupt et al., 1997; Yu et al., 2000) . Therefore, we tested whether the decrease in the p53 protein level in the crt-/-cells could be due to activation of the Mdm2 protein using immunocytochemical localization of Mdm2 protein ( Figure   5 ). In the wt and CRT-crt-/-cells Mdm2 is localized to the cytoplasm ( Figure 5A and 5C). By contrast, in the crt-/-cells Mdm2 is predominantly nuclear (Figure 5B ), colocalizing with the DAPI (Figure 5B superimposed image). Previous reports have shown that p53 acts as a transcriptional regulator of Mdm2 (Wu and Levine, 1997; Saucedo et al., 1998 ). Thus, we tested changes in the level of Mdm2 mRNA by semi-quantitative RT-PCR ( Figure 5D ). There was a 22% decrease in the Mdm2 mRNA in the crt-/-as compared to the wt ( Figure 5D bar graph). This result supports our observations in Figure   1D showing a decrease in the p53 mediated function in the crt-/-cells. On the other hand, 13 western blot analysis using Mdm-2 antibody showed no significant changes in the Mdm2 protein expression in the wt, crt-/-and CRT-crt-/-MEF cells ( Figure 1E ).
Does the localization of p53 and Mdm2 change following UV induction of apoptosis? To address this question we treated wt, crt-/-and CRT-crt-/-MEF cells with UV followed by immunocytochemical staining with specific antibodies to p53 or Mdm2 (Figures 6 and 7) . As seen in Figures 2 and 6 in the absence of CRT there is a defect in the nuclear localization of the endogenous p53. Thus, we transfected these cells with an expression plasmid expressing a p53-EGFP chimeric protein to investigate whether this observation was due to impaired p53 nuclear import or simply because of the decreased p53 protein level. Overexpression of exogenous wild type p53 has been shown to induce apoptosis due to its accumulation in the nucleus (Rotter et al., 1983) . 
Discussion
In the present study, we have for the first time demonstrated a role for CRT in the regulation of p53 function. We have also showed that the increased resistance of crt-/-cells to UV induced apoptosis could be attributed to an impaired nuclear localization of p53 protein. Our results using EGFP-p53 showed that the nuclear import of p53 is inhibited in the crt-/-cells and this effect was specific to CRT because ectopic expression of CRT-HA in the crt-/-cells (CRT-crt-/-) was able to reverse this observation.
Furthermore, we observed a significant decrease in the p53 protein level in the crt-/-cells and embryonic tissue, an effect which was not due to transcriptional regulation of p53
gene. In the present study we also presented evidence for activation of Mdm2 which can induce nuclear export of p53 and its degradation.
How does CRT regulate p53?
In the past two decades much emphasis has been placed on understanding the mechanism of regulation of p53 nuclear localization. This was due to the observation that defects in p53 localization to the nucleus can lead to tumor formation (Schlamp et al., 1997) while overexpression of wild type p53 (or stimulation of this protein by hypoxia) results in accumulation of the protein in the nucleus and induces cell cycle arrest and apoptosis (Ko and Prives, 1996) . The nuclear localization of p53 is dependent on nuclear localization signal (NLS) and nuclear export signal (NES). The p53 protein contains three putative NLS domains at its C-terminus (Shaulsky et al., 1990; Ko and Prives, 1996) . The first NLS (aa 316-321) is the most conserved NLS across different species and has been shown to facilitate the translocation of p53 to the nucleus (Shaulsky et al., 1990; Dang and Lee, 1989) . In our study we showed impaired p53 nuclear localization (Figure 2) .
Recently, CRT has also been shown to be involved in the regulation of nuclear import of NF-AT3 and MEF2C (Li et al., 2002) . Impaired nuclear export of the glucocorticoid receptor was also reported recently in the CRT deficient cells (Holaska et al., 2001) . These observed defects in nuclear transport have been attributed to altered Ca 2+ homeostasis in the CRT deficient cells Li et al., 2002; Holaska et al., 2001; Holaska et al., 2002) . However, not all nuclear import is impaired as evident by normal nuclear transport of GATA4 (Li et al., 2002) , dexamethasone induced nuclear import of glucocorticoid receptor (Holaska et al., 2001 ) and Mdm2 ( Figure 5 ).
Impaired nuclear localization of p53 could also be mediated by increased activity of nuclear export of p53. There are two NES sequences in p53, one at the N terminal domain of the protein and the second at the C-terminus located in the tetramerization site (Stommel et al., 1999; Zhang and Xiong, 2001; Lohrum et al., 2001) . Upon activation of p53, it forms a tetramer which masks the latter NES and retains the protein in the nucleus (Stommel et al., 1999) . The nuclear export of p53 involves binding of Mdm2 to the Cterminal part of p53 (Momand et al., 1992; Chen et al., 1995; Yu et al., 2000) , which inhibits its tetramerization (Stommel et al., 1999) exposing the NES sequences to the nuclear export factor CRM1 (Lohrum et al., 2001; Tao and Levine, 1999; Inoue et al., 2001 ). Binding of Mdm2 to p53 mediates p53 ubiquitination and degradation via the proteasome pathway (Haupt et al., 1997; Yu et al., 2000) . Our results showed a significant decrease in the p53 protein level in the crt-/-MEF cells indicating the possibility for degradation of p53 protein in the absence of CRT. We also showed similar decrease in the p53 protein in the crt-/-mouse embryonic tissue, emphasizing that the observation in the MEF cells are not due to immortalization of these cells. We also observed accumulation of Mdm2 in the nuclei of the crt-/-cells. Mdm2 function and nuclear translocation is regulated by AKT/PKB mediated phosphorylation (Mayo et al., 2002; Mayo and Donner, 2001) . Indeed, inhibition of AKT/PKB kinase by PTEN protects p53 protein from ubiquitination by Mdm2 and degradation (Mayo et al., 2002) .
Recently, Kageyama et al., (Kageyama et al., 2002) have shown inhibition of the AKT/PKB signaling pathway following overexpression of CRT in cardiomyocytes (H9c2). These cells are also more prone to apoptosis when cultured in the presence of 1%
FBS and 10 nM retinoic acid (Kageyama et al., 2002) . Therefore it is plausible that in the absence of CRT the AKT/PKB pathway can be activated resulting in phosphorylation of Mdm2 and its nuclear translocation. Indeed our results show that in the absence of CRT Mdm2 is activated and translocated to the nucleus. When in the nucleus Mdm2 interacts with p53 and both proteins are exported from the nucleus and degraded by the proteasome pathway in the cytosol.
Under stress condition such as UV irradiation, chemotherapeutic agents, or hypoxia p53
is stabilized and accumulates in the nucleus (Ashcroft et al., 2000; Lain et al., 1999a; Lain et al., 1999b; Zhang and Xiong, 2001) where it activates expression of the stress response genes (Middeler et al., 1997) . On the other hand, these stress conditions result in the localization of the Mdm2 protein in the cytoplasm and thus protect p53 protein from the Mdm2 mediated degradation (Wadgaonkar and Collins, 1999) . UV treatment of the showed a significantly lower p53 signal and the nuclear p53 observed was punctate in nature and seems to be associated with the nucleolus. This pattern of nuclear localization of p53 has been recently attributed to the latent form of p53 in HepG2 cell lines (Rubbi and Milner, 2000) . This suggests that in crt-/-cells the UV induced nuclear accumulation of p53 is perhaps due to decreased Mdm2 activity but the stabilized p53 does not efficiently activate p53 downstream activities. Thus we conclude that the increased resistance of the crt-/-cells to UV induced apoptosis could be due to both a decrease in the p53 protein stability and its impaired nuclear localization. were pre-treated with ALLN (as described in Materials and Methods) followed by exposure to UV (25J/m 2 ). Cells were incubated for 6 hrs at 37 °C (in the presence of ALLN, recovery time) then were fixed and labeled with a monoclonal antibody to p53 followed by FITC labeled secondary antibody (A, B, C). To visualize the nuclei, cells were also stained with DAPI. The FITC and DAPI images captured by an epi-fluorescent microscope were superimposed for co-localization. crt-/-and (C) CRT-crt-/-were pre-treated with ALLN (as described in Materials and Methods), followed by exposure to UV (25J/m 2 ). Cells were incubated for 6 hrs at 37 °C 
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